Nebacumab
Nebacumab is a human monoclonal antibody developed for the treatment of sepsis. It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Nebacumab
Nebacumab is a human monoclonal antibody developed for the treatment of sepsis. It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.
has abstract
Nebacumab is a human monoclona ...... mortality in clinical trials.
@en
نيباكوماب هو جسم مضاد وحيد الن ...... ب الوفيات في التجارب السريرية.
@ar
CAS number
138661-01-5
FDA UNII code
908FWN27WK
KEGG
Wikipage page ID
19,714,394
page length (characters) of wiki page
Wikipage revision ID
962,481,442
Link from a Wikipage to another Wikipage
ATC prefix
J06
@en
ATC suffix
BC01
@en
CAS number
ChemSpiderID
none
@en
KEGG
D05126
@en
mab type
mab
@en
source
u
@en
target
endotoxin
@en
type
mab
@en
Verifiedfields
changed
@en
verifiedrevid
458,283,142
wikiPageUsesTemplate
comment
Nebacumab is a human monoclona ...... mortality in clinical trials.
@en
نيباكوماب هو جسم مضاد وحيد الن ...... ب الوفيات في التجارب السريرية.
@ar
label
Nebacumab
@en
نيباكوماب
@ar